Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-09 11:30 am Purchase | 13G | PMV PHARMACEUTICALS INC PMVP | VANGUARD GROUP INC | 2,753,606 6.03% | 105,660 (+3.99%) | View |
| 2023-01-31 1:58 pm Purchase | 13G | PMV PHARMACEUTICALS INC PMVP | BlackRock Inc. BLK | 3,451,367 7.6% | 911,543 (+35.89%) | View |
| 2023-01-25 12:18 pm Sale | 13G | PMV PHARMACEUTICALS INC PMVP | JPMORGAN CHASE & CO JPM | 4,004,767 8.7% | -580,692 (-12.66%) | View |
| 2023-01-24 2:44 pm Sale | 13G | PMV PHARMACEUTICALS INC PMVP | Cowen Financial Products LLC | 1,500,326 3.28% | -799,674 (-34.77%) | View |
| 2022-07-11 1:28 pm Purchase | 13G | PMV PHARMACEUTICALS INC PMVP | STATE STREET CORP STT | 5,171,490 11.35% | 5,171,490 (New Position) | View |
| 2022-07-07 10:06 am Purchase | 13G | PMV PHARMACEUTICALS INC PMVP | JPMORGAN CHASE & CO JPM | 4,585,459 10% | 1,419,009 (+44.81%) | View |
| 2022-06-17 4:02 pm Purchase | 13G | PMV PHARMACEUTICALS INC PMVP | CITADEL ADVISORS LLC | 2,409,842 5.3% | 2,409,842 (New Position) | View |
| 2022-04-01 5:06 pm Unchanged | 13D | PMV PHARMACEUTICALS INC PMVP | ORBIMED ADVISORS LLC | 6,589,330 14.5% | 0 (Unchanged) | View |
| 2022-02-14 5:01 pm Sale | 13G | PMV PHARMACEUTICALS INC PMVP | VIKING GLOBAL INVESTORS LP | 1,790,284 3.9% | -573,778 (-24.27%) | View |
| 2022-02-14 4:16 pm Purchase | 13G | PMV PHARMACEUTICALS INC PMVP | Boxer Capital LLC | 2,838,236 6.3% | 570,000 (+25.13%) | View |
| 2022-02-14 4:00 pm Sale | 13G | PMV PHARMACEUTICALS INC PMVP | Nextech V Oncology S.C.S. SICAV-SIF | 1,385,807 3.1% | -1,142,483 (-45.19%) | View |
| 2022-02-14 08:39 am Purchase | 13G | PMV PHARMACEUTICALS INC PMVP | RTW INVESTMENTS LP | 2,980,960 6.6% | 2,980,960 (New Position) | View |
| 2022-02-14 07:17 am Sale | 13G | PMV PHARMACEUTICALS INC PMVP | Euclidean Capital LLC | 2,336,909 5.1% | -118,290 (-4.82%) | View |
| 2022-02-14 06:51 am Sale | 13G | PMV PHARMACEUTICALS INC PMVP | INTERWEST PARTNERS X LP | 3,249,544 7.2% | -3,220,367 (-49.77%) | View |
| 2022-02-11 10:06 am Sale | 13G | PMV PHARMACEUTICALS INC PMVP | Avoro Capital Advisors LLC | 1,465,000 3.2% | -885,267 (-37.67%) | View |
| 2022-02-10 08:32 am Purchase | 13G | PMV PHARMACEUTICALS INC PMVP | VANGUARD GROUP INC | 2,647,946 5.84% | 2,647,946 (New Position) | View |
| 2022-02-04 4:12 pm Purchase | 13G | PMV PHARMACEUTICALS INC PMVP | BlackRock Inc. BLK | 2,539,824 5.6% | 2,539,824 (New Position) | View |
| 2022-01-26 11:54 am Purchase | 13G | PMV PHARMACEUTICALS INC PMVP | JPMORGAN CHASE & CO JPM | 3,166,450 6.9% | 3,166,450 (New Position) | View |
| 2022-01-19 3:43 pm Purchase | 13G | PMV PHARMACEUTICALS INC PMVP | Cowen Financial Products LLC | 2,300,000 5.07% | 2,300,000 (New Position) | View |
| 2021-10-18 3:50 pm Sale | 13G | PMV PHARMACEUTICALS INC PMVP | Euclidean Capital LLC | 2,455,199 5.4% | -2,218,624 (-47.47%) | View |